Cargando…

783 IMPACT OF COVID-19 RELATED DISRUPTIONS TO COLORECTAL CANCER SCREENING PROGRAMS IN THREE COUNTRIES: A COMPARATIVE MODELLING STUDY

Detalles Bibliográficos
Autores principales:	De Jonge, Lucie, Worthington, Joachim, Wifferen, Francine v., Iragorri, Nicolas, Peterse, Elisabeth F., Lew, Jie-Bin, Greuter, Marjolein J., Smith, Heather, Feletto, Eleonora, Yong, Jean Hai Ein, Canfell, Karen, Coupe, Veerle, Lansdorp-Vogelaar, Iris
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AGA Institute. Published by Elsevier Inc. 2021
Materias:	AGA Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8108224/ http://dx.doi.org/10.1016/S0016-5085(21)01128-8

Ejemplares similares

Potential global loss of life expected due to COVID-19 disruptions to organised colorectal cancer screening
por: Worthington, Joachim, et al.
Publicado: (2023)

Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study
por: de Jonge, Lucie, et al.
Publicado: (2021)

Prioritisation of colonoscopy services in colorectal cancer screening programmes to minimise impact of COVID-19 pandemic on predicted cancer burden: A comparative modelling study
por: van Wifferen, Francine, et al.
Publicado: (2022)

652: IMPACT AND RECOVERY FROM COVID-19-RELATED DISRUPTIONS IN COLORECTAL CANCER SCREENING AND CARE: A SCENARIO ANALYSIS
por: Puttelaar, Rosita van den, et al.
Publicado: (2022)

Resilience of a FIT screening programme against screening fatigue: a modelling study
por: Greuter, Marjolein J. E., et al.
Publicado: (2016)

Improving Australian National Bowel Cancer Screening Program outcomes through increased participation and cost-effective investment
por: Worthington, Joachim, et al.
Publicado: (2020)

Effects of cancer screening restart strategies after COVID-19 disruption
por: Kregting, Lindy M., et al.
Publicado: (2021)

Correction: Effects of cancer screening restart strategies after COVID-19 disruption
por: Kregting, Lindy M., et al.
Publicado: (2021)

Comparing the Cost-Effectiveness of Innovative Colorectal Cancer Screening Tests
por: Peterse, Elisabeth F P, et al.
Publicado: (2020)

Su1077: PANCREATIC CANCER (PC) MORTALITY RATES ARE DECREASING IN YOUNG MEN BUT NOT YOUNG WOMEN IN THE US, 2000 – 2019: A POPULATION-BASED TIME-TREND ANALYSIS USING THE CDC'S NATIONAL CENTER OF HEALTH STATISTICS (NCHS) DATABASE
por: Abboud, Yazan, et al.
Publicado: (2022)

Effects of cancer screening restart strategies after COVID-19 disruption
por: Kregting, L., et al.
Publicado: (2020)

Risk‐stratified strategies in population screening for colorectal cancer
por: Lansdorp‐Vogelaar, Iris, et al.
Publicado: (2021)

Su1488: WITHIN 6 MONTHS FROM COVID-19 BNT162B2 VACCINE PATIENTS WITH INFLAMMATORY BOWEL DISEASES TREATED WITH ANTI-TNFα HAVE SIGNIFICANTLY LOWER SEROLOGIC RESPONSES
por: Rabinowitz, Keren M., et al.
Publicado: (2022)

Health system costs and days in hospital for colorectal cancer patients in New South Wales, Australia
por: Goldsbury, David E., et al.
Publicado: (2021)

Optimising colorectal cancer screening in Shanghai, China: a modelling study
por: Cenin, Dayna, et al.
Publicado: (2022)

COVID-19 and Cancer Global Modelling Consortium (CCGMC): A global reference to inform national recovery strategies
por: Soerjomataram, Isabelle, et al.
Publicado: (2022)

AGA Institute Rapid Review and Recommendations on the Role of Pre-Procedure SARS-CoV-2 Testing and Endoscopy
por: Sultan, Shahnaz, et al.
Publicado: (2020)

AGA Institute Rapid Review of the Gastrointestinal and Liver Manifestations of COVID-19, Meta-Analysis of International Data, and Recommendations for the Consultative Management of Patients with COVID-19
por: Sultan, Shahnaz, et al.
Publicado: (2020)

AGA-Mitteilungen
Publicado: (2020)

AGA-Mitteilungen
Publicado: (2020)

Su1189 SAFETY OF IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH PREEXISTING INFLAMMATORY BOWEL DISEASE AND MICROSCOPIC COLITIS
por: Grover, Shilpa, et al.
Publicado: (2020)

Su1187 ALMOST EVERYTHING CAUSES DIARRHEA: GASTROINTESTINAL MANIFESTATIONS OF ACUTE RESPIRATORY INFECTIONS AMONG 3,510 INDIVIDUALS IN A COMMUNITY-BASED STUDY
por: Newman, Kira L., et al.
Publicado: (2020)

AGA-Mitteilungen
Publicado: (2020)

Sa101 INCREASING THE LOW-RISK THRESHOLD FOR PATIENTS WITH UPPER GASTROINTESTINAL BLEEDING DURING THE COVID-19 PANDEMIC: A PROSPECTIVE, MULTICENTRE, FEASIBILITY STUDY
por: Dunne, Philip, et al.
Publicado: (2021)

Sa002 IMPACT OF THE COVID-19 PANDEMIC ON A LARGE ORGANIZED COLORECTAL CANCER SCREENING PROGRAM BASED ON FECAL IMMUNOCHEMICAL TESTING AND OPPORTUNISTIC COLONOSCOPY
por: Levin, Theodore R., et al.
Publicado: (2021)

Sa003 COVID-19 PANDEMIC AND REDUCTION OF COLORECTAL CANCER SCREENING RELATED PROCEDURES IN THE CZECH REPUBLIC
por: Suchanek, Stepan, et al.
Publicado: (2021)

Sa004 DECLINING COLORECTAL CANCER SCREENING IN THE AGE OF COVID-19
por: Torres, Jon Alexander, et al.
Publicado: (2021)

Fr089 IMPACT OF COVID-19 ON PANDEMIC MAJOR GASTROENTEROLOGY PROCEDURES, VISITS, AND NEW DIAGNOSIS OF GASTROINTESTINAL CANCERS
por: Khan, Ahmad, et al.
Publicado: (2021)

Sa504 INCIDENCE OF INFLAMMATORY BOWEL DISEASE IN SOUTH ASIAN AND CHINESE PEOPLE: A POPULATION-BASED COHORT STUDY FROM ONTARIO, CANADA
por: Dhaliwal, Jasbir, et al.
Publicado: (2021)

109 THE RISK ASSESSMENT OF NASOGASTRIC INTUBATION, A DAILY CLINICAL PRACTICE, DURING THE COVID-19 THREAT BY AEROSOL GENERATION AND DROPLET SPREAD
por: Verbeure, Wout, et al.
Publicado: (2021)

AGA-Mitteilungen
Publicado: (2021)

775f The Introduction of Faecal Immunochemical Testing as a Triaging Tool for Colorectal Cancer Investigation During the COVID-19 Pandemic. A Service Evaluation and Report.
por: Glover, Ben, et al.
Publicado: (2021)

Corneal Abrasions During Endoscopic Procedures in the COVID-19 Era Are a Preventable Phenomenon: A Quality Improvement Project
por: Haghighat, Shida, et al.
Publicado: (2021)

Improving Colorectal Cancer Screening and Polyp Surveillance During the COVID-19 Pandemic
por: Mujtaba, Sobia, et al.
Publicado: (2021)

Sa143 THE RISK OF COVID-19 IS HIGHER IN FEMALES USING PROTON PUMP INHIBITORS
por: Ghoneim, Sara, et al.
Publicado: (2021)

427 AEROSOL MODELING AND MITIGATION STRATEGIES
por: Jaruvongvanich, Veeravich, et al.
Publicado: (2021)

Fr003 TRUE PREVALENCE OF SARS-COV-2 INDUCED DIARRHEA AMONG YOUNG AND OLDER ADULTS: A MULTICENTER STUDY
por: Perisetti, Abhilash, et al.
Publicado: (2021)

731 FAILURE TO DEVELOP NEUTRALIZING ANTIBODIES FOLLOWING SARS-COV-2 INFECTION IN YOUNG PATIENTS WITH INFLAMMATORY BOWEL DISEASE RECEIVING BIOLOGICS
por: Dailey, Joelynn, et al.
Publicado: (2021)

Su093 GUT-BRAIN AXIS AND IRRITABLE BOWEL SYNDROME DURING SARS COV-2 PANDEMIC. A SURVEY BASED STUDY.
por: Piskorz, Maria, et al.
Publicado: (2021)

Fr001 PROTON PUMP INHIBITOR AND RISK OF SARS-COV-2 INFECTION: A MULTI-CENTER EXPERIENCE
por: Silverman, Anna L., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mbcge9vu0nde2e20a3b2t3le8q